摘要:
A distribution system for distributing dosed amounts of a treatment substance to a plurality of injectors of an egg injection device, and to an injection device equipped with such a distribution system. The distribution system comprises at least one syringe pump comprising an actuator for actuating the piston of a syringe, a discharge tube connected to the outlet orifice of the syringe, feed tubes connected in parallel to the discharge tube via a valve system, each feed tube being intended to be connected to an injector, and a controller capable of controlling the actuator and the valve system for distributing dosed amount of substance contained in the chamber through the feed tubes, to injectors.
摘要:
An injector for injecting at least one substance into eggs, comprising an injection body that can be moved between a raised position and an injection position, and equipped with an injection conduit, an injection needle, a guiding and protection tube of the needle subject to elastic stress by elastic means to an idle position and capable of being moved towards a retracted position by pressing its distal end against an egg when the injector is in the injection position. The injector is equipped with control means for controlling the supply of said injection conduit with at least one substance, said tube cooperating with said control means to disable the supply of said injection conduit when said tube is in the idle position and to enable the supply of said conduit when said tube is in the retracted position.
摘要:
Disclosed are compositions comprising and methods of using sulphated or phoshated polysaccharides for the treatment of diseases caused by herpes viruses, more particularly by alpha-herpes viruses, and in particular by HSV-1 and HSV-2, as well as by strains of these viruses which are resistant to known antiviral agents.
摘要:
A living animals conveying device for sorting animals with respect to a characteristic such as color, size, gender, or weight. In the case of chicks, an embodiment of the invention includes a section for conveying chicks with chicks positioned in buckets with their wings spread out, and an automatic chicks sexing system. A first endless bucket conveyor comprising pre-positioning buckets able to individually receive and transport a living animal, is oriented with respect to a second endless bucket conveyor, comprising sorting buckets able to individually receive and transport a living animal, the first conveyor and the second conveyor being arranged in such a way that each pre-positioned living animal in a pre-positioning bucket falls from the pre-positioning bucket into a sorting bucket arranged below the pre-positioning bucket.
摘要:
A living animals conveying device for sorting animals with respect to a characteristic such as color, size, gender, or weight. In the case of chicks, an embodiment of the invention includes a section for conveying chicks with chicks positioned in buckets with their wings spread out, and an automatic chicks sexing system. A first endless bucket conveyor comprising pre-positioning buckets able to individually receive and transport a living animal, is oriented with respect to a second endless bucket conveyor, comprising sorting buckets able to individually receive and transport a living animal, the first conveyor and the second conveyor being arranged in such a way that each pre-positioned living animal in a pre-positioning bucket falls from the pre-positioning bucket into a sorting bucket arranged below the pre-positioning bucket.
摘要:
The invention relates Lo the use of laminarine, preferably in the soluble form thereof or an oligolaminarine, for the production of a medicament for treatment of septicemia and septic shock.
摘要:
The invention concerns endofucanases suitable for preparing fuco-oligosaccharides by enzymatic hydrolysis of fucanes. It also concerns a bacterium producing endofucanases and the preparation of said enzyme from the bacterium. It further concerns endofucanase genes and it finally concerns the use said fuco-oligosaccharides for plant protection.
摘要:
Therapeutical method comprising administration to a patient of an effective amount of especially soluble laminarin for the treatment of tumors and more generally of cancers of the group comprising breast cancer, lung cancer, oesophagus cancer, stomach cancer, intestine and colon cancers, and for the treatment of viral, bacterial and fungal diseases as well as diseases related to immunostimulant deficiencies of human beings and warm-blood animals.
摘要:
The invention relates to the novel Cytophaga drobachiensis strain deposited in the DSMZ Collection (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (German Collection of Microorganisms and Cell Cultures)) on May 8, 1998 under the number DSM 12170, the agaA gene coding for a &bgr;-agarase and having SEQ ID No. 1, the agaB gene coding for a &bgr;-agarase and having SEQ ID No. 3, said genes coding for a &bgr;-agarase of Cytophaga drobachiensis DSM 12170, and the specific nucleic acid sequence of the agaA gene coding for a specific peptide fragment AgaA′ which has conserved &bgr;-agarase activity, and having SEQ ID No. 5, as well as the protein AgaA of C. drobachiensis DSM 12170 having SEQ ID No. 2, the protein AgaB of C. drobachiensis DSM 12170 having SEQ ID No. 4 and said peptide fragment AgaA′ of C. drobachiensis DSM 12170 having SEQ ID No. 6.
摘要翻译:本发明涉及存在于DSMZ Collection(Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH(German Collection of Microorganisms and Cell Cultures))中的新颖的细胞托氏菌(Cytophaga drobachiensis),编号为DSM 12170,编码为β的agaA基因 - 具有SEQ ID No.1,编码β-琼脂糖酶并具有SEQ ID No.3的agaB基因的所述编码所述的编码Cytophaga drobachiensis DSM 12170的β-琼脂糖酶的基因,以及agaA的特异性核酸序列 编码具有保守的β-琼脂糖酶活性并具有SEQ ID No.5的特异性肽片段AgaA'的基因,以及具有SEQ ID No.2的C. drobachiensis DSM 12170的蛋白质AgaA,C的蛋白质AgaB。 具有SEQ ID No.4的drobachiensis DSM 12170和具有SEQ ID No.6的C. drobachiensis DSM 12170的所述肽片段AgaA'。
摘要:
The present invention provides a method to potentiate and stimulate natural defensive reactions of plants to a pathogenic agent. The method comprises application to plants of a composition comprising an effective amount of one or more oligo &bgr; 1-3 glucans composed of 3 to 250 monosaccharide units and a vehicle, wherein the effective amount of oligo &bgr; 1-3 glucans in the composition does not directly stimulate natural defensive reactions of plants when the pathogenic agent is absent.